Metabolic syndrome in coronary artery and occlusive vascular diseases: A systematic review;Síndrome metabólica na doença arterial coronariana e vascular oclusiva: Uma revisão sistemática

Arquivos Brasileiros de Cardiologia

Volumn 94, Issue 6, 2010, Pages

  Farias, Daniela Reis Elbert ^a   Pereira, Avany Fernandes ^a   Rosa, Glorimar ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Coronary artery disease; Meta analysis; Metabolic syndrome; Vascular diseases

Indexed keywords

BLOOD VESSEL OCCLUSION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIETARY INTAKE; HEALTH CARE PERSONNEL; HUMAN; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; MORBIDITY; PHYSICAL ACTIVITY; REVIEW; SMOKING CESSATION; STROKE; SYSTEMATIC REVIEW;

ADULT; ARTERIAL OCCLUSIVE DISEASES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 77955598058     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2010000600024     Document Type: Review

References (58)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001; 285: 2486-97.
2. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of WHO a Consultation. Part 1: diagnosis and classification of diabetes mellitus. Genebra; 1999.
3. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999; 16 (5): 442-3.
4. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112 (17): 2735-52.
5. International Diabetes Federation (IDF). The IDF consensus worldwide definition of the metabolic syndrome. 2006 [Acessed on 2007 Oct 10]. Available from: http://www.idf.org/webdata/docs/Meta-syndrome-definition.pdf.
6. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet. 2005; 365: 1415-28.
7. Grundy SM. Metabolic syndrome: what is it and how should I treat it? ACC Curr J Rev. 2003; 12 (3): 37-40.
8. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W, et al. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians. Diabetes Care. 2003; 26: 861-7.
9. Pereira MA, Jacobs DRJ, Van Horn L, Slattery ML, Kartashov AI, Ludwig DS. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the Cardia Study. JAMA. 2002; 287 (16): 2081-9.
10. Athyros VG, Ganotakis ES, Elisaf MS, Liberopoulos EN, Goudevenos IA, Karagiannis A. Prevalence of vascular disease in metabolic syndrome using three proposed definitions. Int J Cardiol. 2007; 117: 204-10.
11. Lerário DDG, Gimeno SG, Franco LJ, Iunes M, Ferreira SRG. Excesso de peso e gordura abdominal para a síndrome metabólica em nipo-brasileiros. Rev Saude Publica. 2002; 36 (1): 4-11.
12. Pousada JMDC, Britto MMS, Cruz T, Lima ML, Lessa I, Lemaire DC, et al. The metabolic syndrome in spanish migrants to Brazil: unexpected results. Diabetes Res Clin Pract. 2006; 72: 75-80.
13. Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CDA, Bouter LM, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn study. Circulation. 2005; 112: 666-73.
14. American College of Endocrinology. Executive summary of the position statement on the insulin resistance syndrome. Endocr Pract. 2003; 9 (3):237-9.
15. Hamburg NM, Larson MG, Vita JA, Vasan RS, Keyes MJ, Widlansky ME, et al. Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in framingham offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol. 2008; 101 :82-8.
16. Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327: 557-60.
18. Wierzbicki AS, Nishtar S, Lumb PJ, Lambert-Hammill M, Crook MA, Marber MS, et al. Waist circumference, metabolic syndrome and coronary artery disease in a Pakistani cohort. Int J Cardiol. 2008; 128: 77-82. (Pubitemid 351916710)
19. Hajer GR, Graaf YVD, Olijhoek JK, Verhaar MC, Visseren FLJ. Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart. 2007; 93: 216-20.
20. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes. Diabetes Care. 2007; 30: 8-13.
21. Stein E, Kushnerc H, Giddingd S, Falknera B. Plasma lipid concentrations in nondiabetic African American adults: associations with insulin resistance and the metabolic syndrome. Metabolism. 2007; 56: 954-60.
22. Eberly LE, Prineas R, Cohen JD, Vazquez G, Zhi X, Neaton JD, et al. Metabolic syndrome. Diabetes Care. 2006; 29: 123-30.
23. Pollex RL, Al-Shali KZ, House AA, Spence JD, Fenster A, Mamakeesick M, et al. Relationship of the metabolic syndrome to carotid ultrasound traits. Cardiovasc Ultrasound. 2006; 4: 28.
24. Girman CJ, Dekker JM, Rhodes T, Nijpels G, Stehouwer CDA, Bouter LM, et al. An exploratory analysis of criteria for the metabolic syndrome and its prediction of long-term cardiovascular outcomes: the Hoorn Study. Am J Epidemiol. 2005; 162: 438-47.
25. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Wilson PW. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes. 2005; 54: 3252-7.
26. Wilson MPWF, D'Agostino RB, Parise H, Sullivan L, James B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 Diabetes Mellitus. Circulation. 2005; 112: 3066-72.
27. Chinali M, Devereux RB, Howard BV, Roman MJ, Bella JN, Liu JE, et al. Comparison of cardiac structure and function in american indians with and without the metabolic syndrome: the Strong Heart Study. Am J Cardiol. 2004; 93: 40-4.
28. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study. Circulation. 2004; 109: 706-13.
29. Ninomiya J, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen R. Association of the Metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation. 2004; 109: 42-6.
30. Caminiti G, Volterrani M, Marazzi G, Massaro R, Vitale C, Gatta L, et al. Metabolic syndrome predicts lower functional recovery in female but not in male patients after an acute cardiac event. Int J Cardiol. 2008. (In press).
31. Kasai T, Miyauchi K, Kubota N, Tamura H, Kojima T, Yokoyama K, et al. The relationship between the metabolic syndrome defined by various criteria and the extent of coronary artery disease. Atherosclerosis. 2008; 197: 944-50.
32. Gomez Rosso L, Benitez MB, Fornari MC, Berardi V, Lynch S, Schreier L, et al. Alterations in cell adhesion molecules and other biomarkers of cardiovascular disease in patients with metabolic syndrome. Atherosclerosis. 2008; 199: 415-23.
33. Ryan MC, Farin HMF, Abbasi F, Reaven GM. Comparison of waist circumference versus body mass index in diagnosing metabolic syndrome and identifying apparently healthy subjects at increased risk of cardiovascular disease. Am J Cardiol. 2008; 102: 40-6.
34. Lapointe A, Couillard C, Piche ME, Weisnagel SJ, Bergeron J, Nadeau A, et al. Circulating oxidized LDL is associated with parameters of the metabolic syndrome in postmenopausal women. Atherosclerosis. 2007; 191 (2): 362-8.
35. Brevetti G, Schiano V, Sirico G, Giugliano G, Laurenzano E, Chiariello M. Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity. J Vasc Surg. 2006; 44: 101-7.
36. Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease Thromb Res. 2007; 120: 245-50.
37. Dursunoglu D, Evrengül H, Tanriverdi H, Kuru Ö, Gür F, Kaftan A, et al. Do female patients with metabolic syndrome have masked left ventricular dysfunction? Anadolu Kardiyol Derg. 2005; 5: 283-8.
38. Gorter PM, Olijhoek JK, Graaf YVD, Algra A, Rabelink TJ, Visseren FLJ. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis. 2004; 173: 363-9.
39. Reilly M, Wolfe ML, Rhodes T, Girman C, Mehta N, Rader DJ. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation. 2004; 110: 803-9.
40. Scuteri A, Najjar SS, Muller DC, Andres R, Hougaku H, Metter EJ, et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol. 2004; 43: 1388-95. (Pubitemid 38496343)
41. Noto D, Barbagallo CM, Cefalú AB, Falletta A, Sapienza M, Cavera G, et al. The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a mediterranean population. Atherosclerosis. 2008; 197: 147-53.
42. Empana JP, Zureik M, Gariepy J, Courbon D, Dartigues JF, Ritchie K, et al. The metabolic syndrome and the carotid artery structure in noninstitutionalized elderly subjects the three-city study. Stroke. 2007; 38: 893-9. (Pubitemid 46568449)
43. Kurl S, Laukkanen JA, Niskanen L, Laaksonen D, Sivenius J, Nyyssonen K, et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke. 2006; 37: 806-11. (Pubitemid 43731913)
44. Langenberg C, Bergstrom J, Scheidt-Nave C, Pfeilschifter J, Barret-Connor E. Cardiovascular death and the metabolic syndrome role of adipositysignaling hormones and inflammatory markers. Diabetes Care. 2006; 29: 1363-9. (Pubitemid 44125936)
45. Najarian RM, Sullivan LM, Kannel WB, Wilson PWF, D'Agostino RB, Wolf PA. Metabolic syndrome compared with type 2 Diabetes Mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med. 2006; 166: 106-11.
46. Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke. 2005; 36: 1212-7. (Pubitemid 40798741)
47. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004; 110: 1245-50.
48. Marroquin OC, Kip KE, Kelley DE, Johnson BD, Shaw LJ, Merz CNB, et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the women's ischemia syndrome evaluation. Circulation. 2004; 109: 714-21.
49. Bellia C, Bivona G, Scazzone C, Ciaccio M. Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease. Ther Clin Risk Manag. 2007; 3 (6): 999-1001.
50. Montalcini T, Gorgone G, Federico D, Ceravolo R, Emanuele V, Sesti G, et al. Association of LDL cholesterol with carotid atherosclerosis in menopausal women affected by the metabolic syndrome. Nutr Metab Cardiovasc Dis. 2005; 15: 368-72.
51. Wang J, Ruotsalainen S, Moilanen L, Lepisto, P, Laakso M, Kuusisto J. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J. 2007; 28: 857-64.
52. Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Manificat L, L'Huillier I, et al. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med. 2005; 165: 1192-8.
53. Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR Jr. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA. 2008; 299 (19): 2287-93.
54. Skoumas J, Papadimitriou L, Pitsavos C, Masoura C, Giotsas N, Chrysohoou C, et al. Metabolic syndrome prevalence and characteristics in Greek adults with familial combined hyperlipidemia. Metabolism. 2007; 56: 135-41.
55. Iribarren C, Go AS, Husson G, Sidney S, Fair JM, Quertermous T, et al. Metabolic syndrome and early-onset coronary artery disease. Is the whole greater than its parts?. J Am Coll Cardiol. 2006; 48: 1800-7.
56. Meigs JB, Wilson PWF, Fox CS, Vasan RS, Nathan DM, Sullivan LM, et al. Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease. J Clin Endocrinol Metab. 2006; 91: 2906-12.
57. Sociedade Brasileira de Cardiologia. I Diretriz brasileira de diagnóstico e tratamento da síndrome metabólica. Arq Bras Cardiol. 2005; 84 (1): 15-24.
58. Sociedade Brasileira de Cardiologia. IV Diretriz brasileira sobre dislipidemias e prevenção da aterosclerose. Arq Bras Cardiol. 2007; 88 (1): 2-19.